161 related articles for article (PubMed ID: 17911515)
1. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
Lewandowski RJ; Wang D; Gehl J; Atassi B; Ryu RK; Sato K; Nemcek AA; Miller FH; Mulcahy MF; Kulik L; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2007 Oct; 18(10):1249-57. PubMed ID: 17911515
[TBL] [Abstract][Full Text] [Related]
2. Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.
Jin B; Wang D; Lewandowski RJ; Ryu RK; Sato KT; Larson AC; Salem R; Omary RA
AJR Am J Roentgenol; 2011 Nov; 197(5):1237-43. PubMed ID: 22021520
[TBL] [Abstract][Full Text] [Related]
3. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma.
Habbel VSA; Zeile M; Stavrou GA; Wacker F; Brüning R; Oldhafer KJ; Rodt T
Abdom Radiol (NY); 2019 Oct; 44(10):3463-3479. PubMed ID: 31332502
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of angiographic perfusion reduction using color-coded digital subtraction angiography during transarterial chemoembolization.
Wang J; Cheng JJ; Huang KY; Zhuang ZG; Zhang XB; Chi JC; Hua XL; Xu JR
Abdom Radiol (NY); 2016 Mar; 41(3):545-52. PubMed ID: 27039326
[TBL] [Abstract][Full Text] [Related]
6. Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.
Gaba RC; Wang D; Lewandowski RJ; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Nov; 19(11):1589-95. PubMed ID: 18818097
[TBL] [Abstract][Full Text] [Related]
7. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
8. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.
Chen X; Xiao E; Shu D; Yang C; Liang B; He Z; Bian D
Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):109-13. PubMed ID: 24284371
[TBL] [Abstract][Full Text] [Related]
11. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
Wang D; Gaba RC; Jin B; Lewandowski RJ; Riaz A; Memon K; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
Radiology; 2014 Aug; 272(2):587-97. PubMed ID: 24678859
[TBL] [Abstract][Full Text] [Related]
12. Objective Measurement of Arterial Flow Before and After Transcatheter Arterial Chemoembolization: A Feasibility Study Using Quantitative Color-Coding Analysis.
Lin YY; Lee RC; Tseng HS; Liu CA; Guo WY; Chang CY
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1494-501. PubMed ID: 25962989
[TBL] [Abstract][Full Text] [Related]
13. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.
Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
World J Gastroenterol; 2004 Apr; 10(8):1152-6. PubMed ID: 15069716
[TBL] [Abstract][Full Text] [Related]
14. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
Rathmann N; Kara K; Budjan J; Henzler T; Smakic A; Schoenberg SO; Diehl SJ
Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.
Jin B; Wang D; Lewandowski RJ; Riaz A; Ryu RK; Sato KT; Larson AC; Salem R; Omary RA
AJR Am J Roentgenol; 2011 Apr; 196(4):919-28. PubMed ID: 21427346
[TBL] [Abstract][Full Text] [Related]
16. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
[TBL] [Abstract][Full Text] [Related]
17. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization.
Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Notsumata K; Toya D; Tanaka N; Mitsui T
Cardiovasc Intervent Radiol; 2006; 29(1):39-48. PubMed ID: 16328697
[TBL] [Abstract][Full Text] [Related]
18. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
20. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
